新型冠状病毒肺炎：临床药理学的决定性时刻？ - Suppr

Suppr

超能文献

COVID-19: A Defining Moment for Clinical Pharmacology?

作者信息

van der Graaf Piet H, Giacomini Kathleen M

机构信息

Certara, Canterbury, UK.

Leiden University, Leiden, The Netherlands.

出版信息

Clin Pharmacol Ther. 2020 Jul;108(1):11-15. doi: 10.1002/cpt.1876.

DOI:10.1002/cpt.1876

PMID:32350861

Abstract

摘要

相似文献

COVID-19: A Defining Moment for Clinical Pharmacology?

Clin Pharmacol Ther. 2020 Jul;108(1):11-15. doi: 10.1002/cpt.1876.

Cationic drugs and COVID-19.

Int J Immunopathol Pharmacol. 2020 Jan-Dec;34:2058738420966078. doi: 10.1177/2058738420966078.

Are there any Therapeutic Options Currently Available for Wuhan Coronavirus?

Antiinflamm Antiallergy Agents Med Chem. 2020;19(2):85-87. doi: 10.2174/1871523019999200228100917.

COVID-19: Small-Molecule Clinical Trials Landscape.

Curr Top Med Chem. 2020;20(18):1577-1580. doi: 10.2174/156802662018200703154334.

Time to Step Up: A Call to Action For the Clinical and Quantitative Pharmacology Community to Accelerate Therapeutics for COVID-19.

Clin Transl Sci. 2020 Jul;13(4):646-648. doi: 10.1111/cts.12824. Epub 2020 Jun 11.

Drug Repurposing Study Pinpoints Potential COVID-19 Antivirals.

JAMA. 2020 Sep 8;324(10):928. doi: 10.1001/jama.2020.15948.

Challenges in Drug Development Posed by the COVID-19 Pandemic: An Opportunity for Clinical Pharmacology.

Clin Pharmacol Ther. 2020 Oct;108(4):699-702. doi: 10.1002/cpt.1879. Epub 2020 May 28.

News Feature: To counter the pandemic, clinicians bank on repurposed drugs.

Proc Natl Acad Sci U S A. 2020 May 19;117(20):10616-10620. doi: 10.1073/pnas.2007346117. Epub 2020 Apr 29.

The challenging pathway towards the identification of SARS-CoV-2/COVID-19 therapeutics.

J Antimicrob Chemother. 2020 Sep 1;75(9):2381-2383. doi: 10.1093/jac/dkaa272.

Repurposing old drugs as antiviral agents for coronaviruses.

Biomed J. 2020 Aug;43(4):368-374. doi: 10.1016/j.bj.2020.05.003. Epub 2020 May 23.

引用本文的文献

Pharmacovigilance and Pharmacoepidemiology as a Guarantee of Patient Safety: The Role of the Clinical Pharmacologist.

J Clin Med. 2022 Jun 20;11(12):3552. doi: 10.3390/jcm11123552.

Pharmacogenomic landscape of COVID-19 therapies from Indian population genomes.

Pharmacogenomics. 2021 Jul;22(10):603-618. doi: 10.2217/pgs-2021-0028. Epub 2021 Jun 18.

Leveraging the Electronic Health Record to Address the COVID-19 Pandemic.

Mayo Clin Proc. 2021 Jun;96(6):1592-1608. doi: 10.1016/j.mayocp.2021.04.008. Epub 2021 Apr 21.

Model-Informed Drug Development for Anti-Infectives: State of the Art and Future.

Clin Pharmacol Ther. 2021 Apr;109(4):867-891. doi: 10.1002/cpt.2198. Epub 2021 Mar 9.

Immunomodulatory Therapeutic Proteins in COVID-19: Current Clinical Development and Clinical Pharmacology Considerations.

J Clin Pharmacol. 2020 Oct;60(10):1275-1293. doi: 10.1002/jcph.1729. Epub 2020 Sep 8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

COVID-19: A Defining Moment for Clinical Pharmacology?

Clin Pharmacol Ther. 2020 Jul;108(1):11-15. doi: 10.1002/cpt.1876.

Cationic drugs and COVID-19.

Int J Immunopathol Pharmacol. 2020 Jan-Dec;34:2058738420966078. doi: 10.1177/2058738420966078.

Are there any Therapeutic Options Currently Available for Wuhan Coronavirus?

Antiinflamm Antiallergy Agents Med Chem. 2020;19(2):85-87. doi: 10.2174/1871523019999200228100917.

COVID-19: Small-Molecule Clinical Trials Landscape.

Curr Top Med Chem. 2020;20(18):1577-1580. doi: 10.2174/156802662018200703154334.

Time to Step Up: A Call to Action For the Clinical and Quantitative Pharmacology Community to Accelerate Therapeutics for COVID-19.

Clin Transl Sci. 2020 Jul;13(4):646-648. doi: 10.1111/cts.12824. Epub 2020 Jun 11.

Drug Repurposing Study Pinpoints Potential COVID-19 Antivirals.

JAMA. 2020 Sep 8;324(10):928. doi: 10.1001/jama.2020.15948.

Challenges in Drug Development Posed by the COVID-19 Pandemic: An Opportunity for Clinical Pharmacology.

Clin Pharmacol Ther. 2020 Oct;108(4):699-702. doi: 10.1002/cpt.1879. Epub 2020 May 28.

News Feature: To counter the pandemic, clinicians bank on repurposed drugs.

Proc Natl Acad Sci U S A. 2020 May 19;117(20):10616-10620. doi: 10.1073/pnas.2007346117. Epub 2020 Apr 29.

The challenging pathway towards the identification of SARS-CoV-2/COVID-19 therapeutics.

J Antimicrob Chemother. 2020 Sep 1;75(9):2381-2383. doi: 10.1093/jac/dkaa272.

Repurposing old drugs as antiviral agents for coronaviruses.

Biomed J. 2020 Aug;43(4):368-374. doi: 10.1016/j.bj.2020.05.003. Epub 2020 May 23.

引用本文的文献

Pharmacovigilance and Pharmacoepidemiology as a Guarantee of Patient Safety: The Role of the Clinical Pharmacologist.

J Clin Med. 2022 Jun 20;11(12):3552. doi: 10.3390/jcm11123552.

Pharmacogenomic landscape of COVID-19 therapies from Indian population genomes.

Pharmacogenomics. 2021 Jul;22(10):603-618. doi: 10.2217/pgs-2021-0028. Epub 2021 Jun 18.

Leveraging the Electronic Health Record to Address the COVID-19 Pandemic.

Mayo Clin Proc. 2021 Jun;96(6):1592-1608. doi: 10.1016/j.mayocp.2021.04.008. Epub 2021 Apr 21.

Model-Informed Drug Development for Anti-Infectives: State of the Art and Future.

Clin Pharmacol Ther. 2021 Apr;109(4):867-891. doi: 10.1002/cpt.2198. Epub 2021 Mar 9.

Immunomodulatory Therapeutic Proteins in COVID-19: Current Clinical Development and Clinical Pharmacology Considerations.

J Clin Pharmacol. 2020 Oct;60(10):1275-1293. doi: 10.1002/jcph.1729. Epub 2020 Sep 8.